These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 14964727)

  • 1. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow.
    Meinel L; Karageorgiou V; Fajardo R; Snyder B; Shinde-Patil V; Zichner L; Kaplan D; Langer R; Vunjak-Novakovic G
    Ann Biomed Eng; 2004 Jan; 32(1):112-22. PubMed ID: 14964727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors.
    Marolt D; Augst A; Freed LE; Vepari C; Fajardo R; Patel N; Gray M; Farley M; Kaplan D; Vunjak-Novakovic G
    Biomaterials; 2006 Dec; 27(36):6138-49. PubMed ID: 16895736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells.
    Mitra D; Whitehead J; Yasui OW; Leach JK
    Biomaterials; 2017 Nov; 146():29-39. PubMed ID: 28898756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds.
    Meinel L; Hofmann S; Karageorgiou V; Zichner L; Langer R; Kaplan D; Vunjak-Novakovic G
    Biotechnol Bioeng; 2004 Nov; 88(3):379-91. PubMed ID: 15486944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial regulation of human mesenchymal stem cell differentiation in engineered osteochondral constructs: effects of pre-differentiation, soluble factors and medium perfusion.
    Grayson WL; Bhumiratana S; Grace Chao PH; Hung CT; Vunjak-Novakovic G
    Osteoarthritis Cartilage; 2010 May; 18(5):714-23. PubMed ID: 20175974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells.
    Wang Y; Kim UJ; Blasioli DJ; Kim HJ; Kaplan DL
    Biomaterials; 2005 Dec; 26(34):7082-94. PubMed ID: 15985292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue.
    Hagenmüller H; Hofmann S; Kohler T; Merkle HP; Kaplan DL; Vunjak-Novakovic G; Müller R; Meinel L
    Ann Biomed Eng; 2007 Oct; 35(10):1657-67. PubMed ID: 17546503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors.
    Augst A; Marolt D; Freed LE; Vepari C; Meinel L; Farley M; Fajardo R; Patel N; Gray M; Kaplan DL; Vunjak-Novakovic G
    J R Soc Interface; 2008 Aug; 5(25):929-39. PubMed ID: 18230586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaffold-free bioprinted osteogenic and chondrogenic systems to model osteochondral physiology.
    Breathwaite EK; Weaver JR; Murchison AC; Treadwell ML; Odanga JJ; Lee JB
    Biomed Mater; 2019 Oct; 14(6):065010. PubMed ID: 31491773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-ceramic composite scaffolds for bioreactor-based bone engineering.
    Lv Q; Deng M; Ulery BD; Nair LS; Laurencin CT
    Clin Orthop Relat Res; 2013 Aug; 471(8):2422-33. PubMed ID: 23436161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated human adipose tissue as a native biomaterial for the generation of a bone organ by endochondral ossification.
    Guerrero J; Pigeot S; Müller J; Schaefer DJ; Martin I; Scherberich A
    Acta Biomater; 2018 Sep; 77():142-154. PubMed ID: 30126590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds.
    Meinel L; Karageorgiou V; Hofmann S; Fajardo R; Snyder B; Li C; Zichner L; Langer R; Vunjak-Novakovic G; Kaplan DL
    J Biomed Mater Res A; 2004 Oct; 71(1):25-34. PubMed ID: 15316936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Condensation-Driven Chondrogenesis of Human Mesenchymal Stem Cells within Their Own Extracellular Matrix: Formation of Cartilage with Low Hypertrophy and Physiologically Relevant Mechanical Properties.
    Yang Y; Liu Y; Lin Z; Shen H; Lucas C; Kuang B; Tuan RS; Lin H
    Adv Biosyst; 2019 Dec; 3(12):e1900229. PubMed ID: 32648682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds.
    Hofmann S; Hagenmüller H; Koch AM; Müller R; Vunjak-Novakovic G; Kaplan DL; Merkle HP; Meinel L
    Biomaterials; 2007 Feb; 28(6):1152-62. PubMed ID: 17092555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrogenesis in perfusion bioreactors using porous silk scaffolds and hESC-derived MSCs.
    Tiğli RS; Cannizaro C; Gümüşderelioğlu M; Kaplan DL
    J Biomed Mater Res A; 2011 Jan; 96(1):21-8. PubMed ID: 20949478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
    Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
    Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds.
    Bjerre L; Bünger CE; Kassem M; Mygind T
    Biomaterials; 2008 Jun; 29(17):2616-27. PubMed ID: 18374976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proteomic analysis of chondrogenic, osteogenic and tenogenic constructs from ageing mesenchymal stem cells.
    Peffers MJ; Collins J; Loughlin J; Proctor C; Clegg PD
    Stem Cell Res Ther; 2016 Sep; 7(1):133. PubMed ID: 27624072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of human ovarian follicular fluid derived mesenchymal stem cells in chitosan/PCL/Zn scaffold for bone tissue regeneration.
    Chandramohan Y; Jeganathan K; Sivanesan S; Koka P; Amritha TMS; Vimalraj S; Dhanasekaran A
    Life Sci; 2021 Jan; 264():118502. PubMed ID: 33031825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondrogenic differentiation of human bone marrow mesenchymal stem cells in chitosan-based scaffolds using a flow-perfusion bioreactor.
    Alves da Silva ML; Martins A; Costa-Pinto AR; Correlo VM; Sol P; Bhattacharya M; Faria S; Reis RL; Neves NM
    J Tissue Eng Regen Med; 2011 Oct; 5(9):722-32. PubMed ID: 21953870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.